DNA methylation-based tumor classification of CNS tumors, using versions 11b6 and 12b6 of the Heidelberg classifier [2], as well as the NCI/Bethesda classifier [41] indicated a consensus match to AT/RT, MYC-activated. Here, MYC is linked to neoplasm.